Certified by Founder Lodge
Curevo Vaccine

START UP
1 Disclosed Funding Rounds $110,000,000
0 Participating Investments
-
Founded date
2017
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Curevo Vaccine is a clinical-stage developer of vaccines for varicella and herpes zoster. Amezosvatein (CRV-101) is an adjuvanted subunit (non-mRNA) vaccine designed to prevent herpes zoster,
Date | Round | Raised | Participating Investors |
---|---|---|---|
March, 19 ,2025 | Series B | $110,000,000 |